Crossmark

Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011–2016) case-control study

Published Online: 2020-01-17

Published Print: 2020-12

Authors

Segagni Lusignani, Luigi

Presterl, Elisabeth http://orcid.org/0000-0003-4395-7403
Zatorska, Beata

Van den Nest, Miriam

Diab-Elschahawi, Magda
License Information

Text and Data Mining valid from 2020-01-17

Version of Record valid from 2020-01-17
More Information

Article History

Received: 2 August 2019

Accepted: 20 December 2019

First Online: 17 January 2020

Ethics approval

: A study protocol was approved by the Ethics Committee of Medical University of Vienna (Ethics Committee No.: 1592/2016).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current